KRISTEN ANDERSON: Open Payments
NPI 1275246522 · MOULTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 50 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $571 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $218 |
| AstraZeneca Pharmaceuticals LP | 5 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| PFIZER INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Lilly USA, LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $35 |
| Dexcom, Inc. | 2 | $35 |
| TOLMAR, INC. | 2 | $30 |
Products named: BREZTRI, Ozempic, XIFAXAN, Kerendia, CAPLYTA, Wegovy, NURTEC ODT, KISUNLA.
Industry payments across AL — which companies pay providers there.
